论文部分内容阅读
目的:探讨绝经期子宫肌瘤经宫瘤消胶囊联合甲睾酮和米非司酮治疗的临床效果。方法:选取我院收治的绝经期子宫肌瘤患者71例作为研究对象,根据入院顺序进行编号并利用随机数表法将所有研究对象分为对照组35例和观察组36例,对照组患者予以甲睾酮+米非司酮治疗,观察组患者在此基础上口服宫瘤消胶囊治疗,观察两组患者的治疗效果。结果:观察组总有效率明显高于对照组(P<0.05);两组患者治疗前各项临床指标无明显差异(p>0.05),治疗后观察组子宫体积、肌瘤体积、促卵泡激素、孕酮、雌二醇均明显优于对照组(P<0.05)。结论:宫瘤消胶囊联合甲睾酮和米非司酮治疗绝经期子宫肌瘤效果显著,值得推广。
Objective: To investigate the clinical effect of menopause uterine fibroids treated by Miyao Capsule combined with methyltestosterone and mifepristone. Methods: Seventy-one patients with uterine myoma of menopause treated in our hospital were selected as research objects. According to the sequence of admission, all subjects were divided into control group (35 cases) and observation group (36 cases) by random number table method. Patients in control group Methyltestosterone + mifepristone treatment, the observation group patients on the basis of oral Gongyu Xiao capsule treatment, the treatment of two groups were observed. Results: The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). There was no significant difference in the clinical indexes between the two groups before treatment (p> 0.05). After treatment, the uterine volume, fibroid volume, follicle stimulating hormone , Progesterone, estradiol were significantly better than the control group (P <0.05). Conclusion: Gongyuhu capsule combined with methyltestosterone and mifepristone in the treatment of menopausal uterine fibroids effect is worthy of promotion.